PéptidosRD.COM

Peptide Blends · Exact presentation

Tri-Heal · 45 mg Blend

Tri-Heal · 45 mg Blend is a declared multi-component single-vial blend. Evidence for each component does not automatically establish the performance of the combination.

Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.

Dosing & Reconstitution Guide

For a 45 mg presentation, the reference concentration of 15 mg/mL mathematically corresponds to 3 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 15 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.15 mg at this concentration.

Standard 8-Week Protocol (3 mL = 15 mg/mL)

The source chart summarizes “500 mcg–2 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.

Standard 8-Week Protocol (3 mL = 15 mg/mL)

WeekDaily Dose (mcg)Daily Dose (mg)Units (per injection)Volume (mL)
Weeks 1–2500 mcg0.5 mg3.3 units*0.033 mL
Weeks 3–41000 mcg1.0 mg6.7 units*0.067 mL
Weeks 5–61500 mcg1.5 mg10 units0.10 mL
Weeks 7–82000 mcg2.0 mg13.3 units0.133 mL

Extended 12-Week Protocol (3 mL = 15 mg/mL)

The source chart summarizes “500 mcg–2 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.

Extended 12-Week Protocol (3 mL = 15 mg/mL)

WeekDaily Dose (mcg)Daily Dose (mg)Units (per injection)Volume (mL)
Weeks 1–2500 mcg0.5 mg3.3 units*0.033 mL
Weeks 3–41000 mcg1.0 mg6.7 units*0.067 mL
Weeks 5–61500 mcg1.5 mg10 units0.10 mL
Weeks 7–82000 mcg2.0 mg13.3 units0.133 mL
Weeks 9–102500 mcg2.5 mg16.7 units0.167 mL
Weeks 11–123000 mcg3.0 mg20 units0.20 mL

Extended 16-Week Protocol (3 mL = 15 mg/mL)

The source chart summarizes “500 mcg–2 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.

Extended 16-Week Protocol (3 mL = 15 mg/mL)

WeekDaily Dose (mcg)Daily Dose (mg)Units (per injection)Volume (mL)
Weeks 1–2500 mcg0.5 mg3.3 units*0.033 mL
Weeks 3–41000 mcg1.0 mg6.7 units*0.067 mL
Weeks 5–61500 mcg1.5 mg10 units0.10 mL
Weeks 7–82000 mcg2.0 mg13.3 units0.133 mL
Weeks 9–102500 mcg2.5 mg16.7 units0.167 mL
Weeks 11–123000 mcg3.0 mg20 units0.20 mL
Weeks 13–143500 mcg3.5 mg23.3 units0.233 mL
Weeks 15–164000 mcg4.0 mg26.7 units0.267 mL

Reconstitution Steps

For a 45 mg presentation, the reference concentration of 15 mg/mL mathematically corresponds to 3 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 15 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.15 mg at this concentration.

Storage Instructions

Proper storage preserves peptide quality.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]

Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]

Allow vials to reach room temperature before opening to reduce condensation uptake.

How This Works

The proposed mechanism depends on the molecular identity and receptor systems described in the literature. A mechanism alone does not establish clinical efficacy.

Potential Benefits & Side Effects

Identity, purity, sterility, stability, and equivalence to studied products cannot be assumed. Adverse effects and interactions may be incompletely characterized.

Source trail

Scientific references and source discovery

How PeptidosRD selects, separates, and reviews sources